Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Maximizing the osteogenic potential of stem cells after expansion in DMEM LG using 99mTc-HDP Labeling

Tobias Grossner, Uwe Haberkorn and Tobias Gotterbarm
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1009;
Tobias Grossner
1Center for orthopaedics, trauma surgery and paraplegiology University Hospital Heidelberg Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
2University of Heidelberg Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Gotterbarm
1Center for orthopaedics, trauma surgery and paraplegiology University Hospital Heidelberg Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1009

Objectives Dulbecco's Modified Eagle Medium low glucose (DMEM LG) is one of the most important standard cell culture media used for tissue engineering of human mesenchymal stem cells (hMSC) worldwide. Until today it’s pretty far unknown which media is to favor after a DMEM LG based cell expansion to maximize the osteogenic differentiation. We developed a novel method to track and quantify the amount of newly produced hydroxylapatit using 99mTc-HDP, as the Diphosphonate binds to newly produced hydroxylapatite by human mesenchymal stem cells in vitro. As we could show in prior studies 99mTc-HDP Labeling is a new, high significant and accurate method.

Methods We have evaluated, after cell expansion in DMEM low glucose, the osteogenic potential of five basal cell culture media in combination with various growth factors. Thus we are able to determine the optimal combination of expansion-, and differentiation media to maximize the production of bone-specific mineral (hydroxylapatite) by these cells. The following media combinations were evaluated: 1) DMEM low glucose 2) DMEM high glucose; 3) Alpha-MEM; 4) DMEM-F12; 5) Verfaillie-Media. The cells were cultured in monolayer 35mm petri dished. After cell culture 5,5 MBq 99mTc-HDP was applied to the dishes, solved in 0,9% NaCl solution. The cultured were incubated for 2 hours followed by repeated washing. Then, the probes were placed under a gamma-camera, using a 256x256 grid. Gammacounts were acquired for 180 seconds. Using regions of interest, the counts emitted by each dish were calculated. A corresponding non-osteogenic negative control was cultured for each donor and group.

Results Cell expansion with DMEM low glucose followed by osteogenic induction with media (5) ,,Verfaillie“-Media showed the highest osteogenic potential over all in the evaluated media combinations with 47328 counts/180 seconds. The corresponding negative control hand an uptake of only 3316 counts/180 seconds. The second highest uptake was noticed for DMEM LG as induction media with 39356 counts/180 seconds, the corresponding negative control had an uptake of 3807 counts/180 seconds, followed by 30847 counts/180 for induction in DMEM HG (negative control 4981 counts/180 seconds) and Alpha-MEM with 28948 counts/180 seconds (negative control 2945 counts/180 seconds). The lowest uptake was shown for osteogenic induction in Berner Media with 2026 counts/180 seconds (negative control 3381 counts/180 seconds). Significance was set to p < 0,05 for students t-Test-analysis. In direct comparison, all osteogenic groups showed a significant higher uptake for the tracer in the osteogenic group compared to the negative control group, except for the Berner media where no significant difference could be calculated.

Conclusions All four media combinations worked very well to archive osteogenic differentiation, except the DMEM-F12+growth factors. Here no osteogenic differentiation could be archived. To get the maximum amount of hydroxylapatite, ,,Verfaillie“-media should be used. As the ,,Verfaillie“-media is a very expansive cell culture media, we will favor DMEM low glucose for the osteogenic induction after cell expansion in DMEM low glucose in the future. DMEM Low Glucose for osteogenic differentiation of human mesenchymal stem cells is still an economic and highly potent cell culture media to favor the deposition of hydroxylapatite.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Maximizing the osteogenic potential of stem cells after expansion in DMEM LG using 99mTc-HDP Labeling
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Maximizing the osteogenic potential of stem cells after expansion in DMEM LG using 99mTc-HDP Labeling
Tobias Grossner, Uwe Haberkorn, Tobias Gotterbarm
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1009;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Maximizing the osteogenic potential of stem cells after expansion in DMEM LG using 99mTc-HDP Labeling
Tobias Grossner, Uwe Haberkorn, Tobias Gotterbarm
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1009;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Dosimetry Posters

  • Measured human dosimetry of 68Ga-DOTA-UBI 29-41, a potential tracer for imaging bacterial infection processes
  • Feasibility of Ultra-Low Dose PET/CT for Evaluation of ACL Grafts Using a Next Generation Digital Detector
  • Standardized biodistribution template for dosimetry collection and reporting
Show more SPECIAL MTA: Dosimetry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire